Screener
Beta Bionics BBNX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Beta Bionics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Operating lease liabilities, net of current portion | 4,921 | 5,365 |
| Deferred revenue, net of current portion | 3,454 | 3,297 |
| Other long-term liabilities | 1,629 | 1,547 |
| Total liabilities | 36,021 | 41,133 |
| Commitments and contingencies (Note 15) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued and outstanding at June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value, 700,000,000 shares authorized; 44,981,606 and 44,360,873 issued and outstanding at June 30, 2026 and December 31, 2025, respectively | 5 | 4 |
Item 1. Financial Statements.
FAQ
- What is Beta Bionics's total liabilities?
- Beta Bionics (BBNX) reported total liabilities of $36.02M in Q2 2026.
- How has Beta Bionics's total liabilities changed year-over-year?
- Beta Bionics's total liabilities increased by 27.1% year-over-year, from $28.34M to $36.02M.
- What is the long-term trend for Beta Bionics's total liabilities?
- Over 2 years (2023 to 2025), Beta Bionics's total liabilities has grown at a -10.6% compound annual growth rate (CAGR), from $51.43M to $41.13M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Beta Bionics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude